WuXi AppTec sues to get its name removed from U.S. blacklist
Pharmaceutical services provider WuXi AppTec Co. Ltd. (2359.HK; 603259.SH) has sued the U.S. Defense Department, seeking to have its name removed from the department’s list of Chinese companies with military…
BRIEF: Heavily oversubscribed TenNor Therapeutics soars in trading debut
Shares of Biotechnology firm TenNor Therapeutics (Suzhou) Ltd. (6872.HK) nearly tripled in their Hong Kong debut on Friday, doubling when trading began and rising throughout the day to close at HK$211, up 179%.…
BRIEF: Zai Lab revenue falls on fading sales for its best-selling drug
Drug developer Zai Lab Ltd. (ZLB.US; 9688.HK) on Thursday reported its revenue fell 6% to $99.6 million in the first quarter from $106.5 million a year earlier, blaming a big…
BRIEF: Sinopharm’s revenue and profit rise, but cash outflow continues in first quarter
Drug wholesaler and retailer Sinopharm Group Co. Ltd. (1099.HK; 600511.SH) on Wednesday reported its revenue increased 6.6% year-over-year to 13.56 billion yuan ($1.99 billion) in the first quarter, while its…
Good Doctor Cloud Healthcare’s ailing margins belie uninspired new listing
The supplier of services for primary healthcare providers has applied for a Hong Kong IPO, reporting strong profit growth last year on non-operational factors Key Takeaways: Good Doctor Cloud Healthcare…
InnoCare hits profit milestone, enters new phase with global expansion, strong pipeline
The innovative drugmaker’s newfound profitability marks its transition into a new stage characterized by stability and virtuous development cycles Key Takeaways: InnoCare posted an annual profit of 644 million yuan,…
BRIEF: Legend Biotech posts strong fourth-quarter revenue gain
Legend Biotech Corp. (LEGN.US) on Tuesday reported strong double-digit revenue growth in last year’s fourth quarter on solid gains for its core Carvykti cancer treatment, lifting the company to a…
